Udo Kellner
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Lung Cancer Research Studies
Papers in
-
- Cancer therapeutics and mechanisms 5
- Molecular Biology Techniques and Applications 3
- Oncology 13
- Pancreatic and Hepatic Oncology Research 4
- Cutaneous Melanoma Detection and Management 2
- Co-authors
- Albert Roessner (7 shared papers)Pierre Rudolph (5 shared papers)Reza Parwaresch (6 shared papers)Frank Gieseler (1 shared paper)Maxwell Sehested (1 shared paper)Peter Buhl Jensen (1 shared paper)Sabine Krueger (3 shared papers)Iris Simón (2 shared papers)
- Journals
- American Journal of Clinical Pathology (2 papers)Lung Cancer (2 papers)Laboratory Investigation (1 paper)The Prostate (1 paper)Cancer Letters (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Udo Kellner
46 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 299
- Oncology 357
- Immunology and Allergy 54
- Microbiology 53
- Molecular Biology 565
Countries citing papers authored by Udo Kellner
This map shows the geographic impact of Udo Kellner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Kellner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Kellner more than expected).
Fields of papers citing papers by Udo Kellner
This network shows the impact of papers produced by Udo Kellner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Kellner. The network helps show where Udo Kellner may publish in the future.
Co-authors
The 25 scholars most cited alongside Udo Kellner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 139 | |
| 2 | 2013 | 109 | |
| 3 | 2005 | 86 | |
| 4 | 2002 | 82 | |
| 5 | 2004 | 69 | |
| 6 | 2001 | 51 | |
| 7 | 2003 | 49 | |
| 8 | Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study. | 1997 | 47 |
| 9 | 1997 | 46 | |
| 10 | 2014 | 43 | |
| 11 | 2000 | 38 | |
| 12 | 2021 | 37 | |
| 13 | 2000 | 37 | |
| 14 | 2004 | 37 | |
| 15 | 2015 | 35 | |
| 16 | 1997 | 34 | |
| 17 | 2020 | 33 | |
| 18 | 2004 | 29 | |
| 19 | 2016 | 26 | |
| 20 | 1991 | 24 |
About Udo Kellner
Udo Kellner is a scholar working on Molecular Biology, Oncology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Molecular Biology Techniques and Applications (3 papers), Lung Cancer Treatments and Mutations (3 papers), Galectins and Cancer Biology (2 papers), Cutaneous Melanoma Detection and Management (2 papers), Neuroblastoma Research and Treatments (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Cancer Research (299 citations), Oncology (357 citations), Immunology and Allergy (54 citations), Microbiology (53 citations) and Molecular Biology (565 citations). Udo Kellner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Albert Roessner, Pierre Rudolph, Reza Parwaresch, Frank Gieseler, Maxwell Sehested, Peter Buhl Jensen, Sabine Krueger, Iris Simón, P. Rudolph and Stefan M. Willems. Their work appears in journals such as American Journal of Clinical Pathology, Lung Cancer, Laboratory Investigation, The Prostate and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.